BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 7721771)

  • 1. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
    Novokhatny V; Medved L; Lijnen HR; Ingham K
    J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain structure and interactions of recombinant urokinase-type plasminogen activator.
    Novokhatny V; Medved L; Mazar A; Marcotte P; Henkin J; Ingham K
    J Biol Chem; 1992 Feb; 267(6):3878-85. PubMed ID: 1310986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
    Boutaud A; Castellino FJ
    Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-type plasminogen activator mutants imitating urokinase in the peptide link between kringle and protease domains and at selected sites within the protease domain.
    Hinzmann B; Wernicke D; Pfeifer M; Zacharias U; Fischer B; Eisenmenger F; Will H
    Eur J Biochem; 1993 Apr; 213(1):437-43. PubMed ID: 8386628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    J Biol Chem; 1988 Dec; 263(35):19083-91. PubMed ID: 3143723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants of the noncatalytic chain of tissue-type plasminogen activator that modulate its association rate with plasminogen activator inhibitor-1.
    de Serrano VS; Castellino FJ
    J Biol Chem; 1990 Jun; 265(18):10473-8. PubMed ID: 2113057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
    Gheysen D; Lijnen HR; PiƩrard L; de Foresta F; Demarsin E; Jacobs P; De Wilde M; Bollen A; Collen D
    J Biol Chem; 1987 Aug; 262(24):11779-84. PubMed ID: 3114253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
    Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin affinity of urokinase-type plasminogen activator. Evidence that Zn2+ mediates strong and specific interaction of single-chain urokinase with fibrin.
    Husain SS
    J Biol Chem; 1993 Apr; 268(12):8574-9. PubMed ID: 8473303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
    Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin.
    Nesheim M; Fredenburgh JC; Larsen GR
    J Biol Chem; 1990 Dec; 265(35):21541-8. PubMed ID: 2123871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activator.
    Lubin IM; Caban R; Runge MS
    J Biol Chem; 1993 Mar; 268(8):5550-6. PubMed ID: 8449917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.
    van Zonneveld AJ; Veerman H; Pannekoek H
    J Biol Chem; 1986 Oct; 261(30):14214-8. PubMed ID: 3021732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.
    Wilhelm OG; Jaskunas SR; Vlahos CJ; Bang NU
    J Biol Chem; 1990 Aug; 265(24):14606-11. PubMed ID: 2117612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L; Lijnen HR; Collen D; Holmes WE
    J Biol Chem; 1987 Aug; 262(22):10855-62. PubMed ID: 2956260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
    Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis.
    Mukhina S; Stepanova V; Traktouev D; Poliakov A; Beabealashvilly R; Gursky Y; Minashkin M; Shevelev A; Tkachuk V
    J Biol Chem; 2000 Jun; 275(22):16450-8. PubMed ID: 10749881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remaining perspectives of mutant and chimeric plasminogen activators.
    Lijnen HR; Collen D
    Ann N Y Acad Sci; 1992 Dec; 667():357-64. PubMed ID: 1309056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.